Type I Interferon Receptors: Biochemistry and Biological Functions*
暂无分享,去创建一个
Paul J. Hertzog | Shamith A. Samarajiwa | S. Samarajiwa | P. Hertzog | Nicole A. de Weerd | Nicole A de Weerd
[1] S. Lata,et al. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. , 2004, Journal of molecular biology.
[2] A. Whitty,et al. Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity. , 2000, Biochemistry.
[3] G. Stark,et al. Mutant U5A cells are complemented by an interferon‐alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. , 1995, The EMBO journal.
[4] S. Fuchs,et al. TYK2 activity promotes ligand-induced IFNAR1 proteolysis. , 2006, The Biochemical journal.
[5] E. Fish,et al. Evidence for glycosphingolipid modification of the type 1 IFN receptor. , 1994, Journal of immunology.
[6] M. Tymms,et al. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[7] S. Rose-John,et al. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. , 2002, Biochimica et biophysica acta.
[8] I. Kola,et al. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. , 2001, Blood.
[9] R. Levy,et al. The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. , 2003, Structure.
[10] L. Platanias. Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.
[11] Differential Responsiveness of a Splice Variant of the Human Type I Interferon Receptor to Interferons* , 1996, The Journal of Biological Chemistry.
[12] A. Alcamí,et al. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.
[13] M. Saraste,et al. FEBS Lett , 2000 .
[14] G Schreiber,et al. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. , 1999, Journal of molecular biology.
[15] J. Sprent,et al. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Fernandez-Botran. Soluble cytokine receptors: their role in immunoregulation , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[17] P. Hertzog,et al. Characterization and transcriptional analysis of the mouse Chromosome 16 cytokine receptor gene cluster , 2003, Mammalian Genome.
[18] G. Lutfalla,et al. Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.
[19] Fuencisla Matesanz,et al. IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response , 2005, Journal of Neuroimmunology.
[20] I. Kola,et al. Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome. , 1997, Human molecular genetics.
[21] P. Hertzog,et al. Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression. , 2002, The Biochemical journal.
[22] W. Windsor,et al. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor , 1995, Nature.
[23] X. Gallet,et al. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. , 2004, Biochemistry.
[24] J. Krolewski,et al. Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor , 2004, Oncogene.
[25] N. Cordani,et al. The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells. , 2005, International journal of oncology.
[26] S. Constantinescu,et al. Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor (*) , 1996, The Journal of Biological Chemistry.
[27] I. Kola,et al. Cloning and Characterization of Soluble and Transmembrane Isoforms of a Novel Component of the Murine Type I Interferon Receptor, IFNAR 2* , 1997, The Journal of Biological Chemistry.
[28] J. Krolewski,et al. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction , 1996, Molecular and cellular biology.
[29] L. Platanias,et al. A Region of the β Subunit of the Interferon α Receptor Different from Box 1 Interacts with Jak1 and Is Sufficient to Activate the Jak-Stat Pathway and Induce an Antiviral State* , 1997, The Journal of Biological Chemistry.
[30] P. Eid,et al. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons. , 2000, European cytokine network.
[31] J. Sprent,et al. Stimulation of naive and memory T cells by cytokines , 1999, Immunological reviews.
[32] D. Novick,et al. Soluble interferon‐α receptor molecules are present in body fluids , 1992 .
[33] D. Stuart,et al. Crystal structure of the extracellular region of human tissue factor , 1994, Nature.
[34] R. Roberts,et al. Antiviral activities of the soluble extracellular domains of type I interferon receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[36] M. Lathrop,et al. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[37] V. Nguyễn,et al. Stat2 Binding to the Interferon-α Receptor 2 Subunit Is Not Required for Interferon-α Signaling* , 2002, The Journal of Biological Chemistry.
[38] J. Scheller,et al. IL-6 transsignaling: the in vivo consequences. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[39] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[40] J. Bazan,et al. Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[41] F. Young. Biochemistry , 1955, The Indian Medical Gazette.
[42] M. Muraguchi,et al. Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C , 1999, Hepatology.
[43] B. Cohen,et al. Ligand-induced association of the type I interferon receptor components , 1995, Molecular and cellular biology.
[44] A. Brass,et al. Gene expression profiling in a mouse model for African trypanosomiasis , 2006, Genes and Immunity.
[45] E. Ratovitski,et al. Identification of mRNAs encoding two different soluble forms of the human interferon α‐receptor , 1994 .
[46] K. Shuai,et al. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.
[47] S. Fuchs,et al. Phosphorylation and Specific Ubiquitin Acceptor Sites Are Required for Ubiquitination and Degradation of the IFNAR1 Subunit of Type I Interferon Receptor* , 2004, Journal of Biological Chemistry.
[48] A. Arulanandam,et al. Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[49] D. Kwiatkowski,et al. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia , 2003, Genes and Immunity.
[50] J. van der Heyden,et al. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. , 2005, Journal of molecular biology.
[51] G. Lutfalla,et al. α and α Interferons and Their Receptor and Their Friends and Relations , 1995 .
[52] H. Whittle,et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[53] M Aguet,et al. Functional role of type I and type II interferons in antiviral defense. , 1994, Science.
[54] M. Gavutis,et al. Differential receptor subunit affinities of type I interferons govern differential signal activation. , 2007, Journal of molecular biology.
[55] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[56] K. Inageda,et al. Genetic variations in humans associated with differences in the course of hepatitis C. , 2004, Biochemical and biophysical research communications.
[57] B. Cohen,et al. The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.
[58] D. Sykes,et al. Free interferon‐α/β receptors in the circulation of patients with adenocarcinoma , 2003 .
[59] G. Feng,et al. Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.
[60] Paul J Hertzog,et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity , 2006, Nature Immunology.
[61] G. Stark,et al. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling , 1997, Molecular and cellular biology.